<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 28 May 2026 20:49:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 26  Filed by: JW Partners, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+26++Filed+by%3A+JW+Partners%2C+LP/26569425.html</link>
   <description>si-local-file:///var/storage/secattach/20260528/26569425.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+26++Filed+by%3A+JW+Partners%2C+LP/26569425.html</guid>
   <pubDate>Thu, 28 May 2026 20:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 26  Filed by: JW Partners, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+26++Filed+by%3A+JW+Partners%2C+LP/26569425.html</link>
   <description>si-local-file:///var/storage/secattach/20260528/26569425.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+26++Filed+by%3A+JW+Partners%2C+LP/26569425.html</guid>
   <pubDate>Thu, 28 May 2026 20:49:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead</title>
   <link>http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Issued on behalf of Conexeu Sciences Inc.&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;&lt;em&gt;Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue regeneration — evolves, the next 18 months matter.&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;left&quot;&gt;NEW YORK, May  27, 2026  (GLOBE NEWSWIRE) -- &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=zTYws5Psc8GXNxoyiOP3thnmUdCRwNjdpmyRCi7v3xrWNYD6VJIAx-Y8kgDYbHOZtqMTWJ3t9lV45k3R4tFOGpCfqCBaHwpz-A1dUObYZJ4l4jgOPfgAXdfl7SQCpSM_uzJOT5IYkRgHO4AH9Stkdg==&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Biotech Insider&lt;/a&gt; News Commentary — For more than fifty years, breast reconstruction has mostly meant one thing: replacement. A silicone shell, filled with gel, designed to restore shape and volume, none of them designed to regenerate the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/After+Fifty+Years+of+Implants%2C+a+Newly+Public+Biotech+Is+Trying+to+Rebuild+the+Breast+Instead/26554363.html</guid>
   <pubDate>Wed, 27 May 2026 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CNXU</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">INMD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PCRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TELA</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: Slotkin Bryan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Slotkin+Bryan/26549940.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549940.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Slotkin+Bryan/26549940.html</guid>
   <pubDate>Tue, 26 May 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: Slotkin Bryan</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Slotkin+Bryan/26549940.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549940.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Slotkin+Bryan/26549940.html</guid>
   <pubDate>Tue, 26 May 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: SCHUTTER EDWARD J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+SCHUTTER+EDWARD+J/26549947.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549947.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+SCHUTTER+EDWARD+J/26549947.html</guid>
   <pubDate>Tue, 26 May 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: SCHUTTER EDWARD J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+SCHUTTER+EDWARD+J/26549947.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549947.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+SCHUTTER+EDWARD+J/26549947.html</guid>
   <pubDate>Tue, 26 May 2026 16:08:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: Gillin Leslie</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Gillin+Leslie/26549858.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549858.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Gillin+Leslie/26549858.html</guid>
   <pubDate>Tue, 26 May 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: Gillin Leslie</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Gillin+Leslie/26549858.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549858.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Gillin+Leslie/26549858.html</guid>
   <pubDate>Tue, 26 May 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: LEWIN NICHOLAS SHERIDAN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+LEWIN+NICHOLAS+SHERIDAN/26549906.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549906.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+LEWIN+NICHOLAS+SHERIDAN/26549906.html</guid>
   <pubDate>Tue, 26 May 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: LEWIN NICHOLAS SHERIDAN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+LEWIN+NICHOLAS+SHERIDAN/26549906.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549906.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+LEWIN+NICHOLAS+SHERIDAN/26549906.html</guid>
   <pubDate>Tue, 26 May 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: Custin Ann</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Custin+Ann/26549925.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549925.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Custin+Ann/26549925.html</guid>
   <pubDate>Tue, 26 May 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 22  Filed by: Custin Ann</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Custin+Ann/26549925.html</link>
   <description>si-local-file:///var/storage/secattach/20260526/26549925.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+22++Filed+by%3A+Custin+Ann/26549925.html</guid>
   <pubDate>Tue, 26 May 2026 16:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
  <item>
   <title>Form  4          ESTABLISHMENT LABS HOLDI  For: May 20  Filed by: JW Opportunities Fund, LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+20++Filed+by%3A+JW+Opportunities+Fund%2C+LLC/26543044.html</link>
   <description>si-local-file:///var/storage/secattach/20260522/26543044.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ESTABLISHMENT+LABS+HOLDI++For%3A+May+20++Filed+by%3A+JW+Opportunities+Fund%2C+LLC/26543044.html</guid>
   <pubDate>Fri, 22 May 2026 17:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ESTA</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.31243832</category>
   	  </item>
 </channel>
</rss>
